Posted by Clinical Lab Products | Jun 4, 2004 | Miscellaneous |
By Gary Tufel The US Food and Drug Administration’s recent approval of Sysmex America’s pocH-100i™ has cleared the way for the complete blood count (CBC) and three-part differential hematology analyzer to be marketed to the clinica
Read MorePosted by Clinical Lab Products | Apr 3, 2004 | Miscellaneous |
A Look at the Theoretical and Practical Advantages of Serum Free Light Chain Immunoassays
Read MorePosted by Clinical Lab Products | Mar 10, 2004 | Miscellaneous |
Dade Behring Signs Manufacturing Licensing Agreement for FSAP Dade Behring and Aventis Behring LLC have signed a license agreement that provides Dade Behring with worldwide in vitro diagnostic rights to any Aventis Behring inventions that relate t
Read MorePosted by Clinical Lab Products | Feb 1, 2004 | Cancer, Hematology & Serology, Hematology Instrumentation |
By Nicholas Borgert Advances in hematologic disease testing are giving physicians the comprehensive information they need for more effective treatment protocols for those diagnosed with blood disorders. Over the past 40 years, refinements in te
Read MorePosted by Clinical Lab Products | Jan 10, 2004 | Cancer, Miscellaneous |
ASH Meeting Addresses Developments in Treating Blood Disorders Approximately 20,000 physicians and scientists from around the world gathered for the 45th Annual Meeting of the American Society of Hematology (ASH), December 6–9, 2003, at the S
Read More